Latisse VS FDA

"As for Latisse, its flashy ad campaign has caught ire from at least one other group: the Food and Drug Administration, which in September warned Allergan that promotional materials on the drug’s Web site omitted or minimized certain risks. All the more reason to consider the cheaper nonprescription option we mention in our video. After all, Brooke got by all these years without Latisse. And she’s done OK, no?"